NM_000368.5:c.2626-4dupT
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000368.5(TSC1):c.2626-4dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0082 ( 26 hom., cov: 0)
Exomes 𝑓: 0.12 ( 1177 hom. )
Consequence
TSC1
NM_000368.5 splice_region, intron
NM_000368.5 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.517
Publications
6 publications found
Genes affected
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC1 Gene-Disease associations (from GenCC):
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Genomics England PanelApp
- lung lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 9-132897613-G-GA is Benign according to our data. Variant chr9-132897613-G-GA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 195562.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00816 (849/104078) while in subpopulation AFR AF = 0.0232 (560/24108). AF 95% confidence interval is 0.0216. There are 26 homozygotes in GnomAd4. There are 409 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 849 AD gene.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000368.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC1 | NM_000368.5 | MANE Select | c.2626-4dupT | splice_region intron | N/A | NP_000359.1 | Q92574-1 | ||
| TSC1 | NM_001406592.1 | c.2626-4dupT | splice_region intron | N/A | NP_001393521.1 | X5D9D2 | |||
| TSC1 | NM_001406593.1 | c.2626-4dupT | splice_region intron | N/A | NP_001393522.1 | Q92574-1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC1 | ENST00000298552.9 | TSL:1 MANE Select | c.2626-4dupT | splice_region intron | N/A | ENSP00000298552.3 | Q92574-1 | ||
| TSC1 | ENST00000490179.4 | TSL:3 | c.2626-4dupT | splice_region intron | N/A | ENSP00000495533.2 | Q92574-1 | ||
| TSC1 | ENST00000643875.1 | c.2626-4dupT | splice_region intron | N/A | ENSP00000495158.1 | Q92574-1 |
Frequencies
GnomAD3 genomes AF: 0.00810 AC: 843AN: 104078Hom.: 25 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
843
AN:
104078
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.170 AC: 17641AN: 103824 AF XY: 0.173 show subpopulations
GnomAD2 exomes
AF:
AC:
17641
AN:
103824
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.116 AC: 140253AN: 1205502Hom.: 1177 Cov.: 0 AF XY: 0.117 AC XY: 69804AN XY: 598492 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
140253
AN:
1205502
Hom.:
Cov.:
0
AF XY:
AC XY:
69804
AN XY:
598492
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
2672
AN:
27258
American (AMR)
AF:
AC:
3448
AN:
26354
Ashkenazi Jewish (ASJ)
AF:
AC:
2481
AN:
19420
East Asian (EAS)
AF:
AC:
4154
AN:
34050
South Asian (SAS)
AF:
AC:
7473
AN:
63148
European-Finnish (FIN)
AF:
AC:
3905
AN:
32066
Middle Eastern (MID)
AF:
AC:
492
AN:
4416
European-Non Finnish (NFE)
AF:
AC:
109822
AN:
948964
Other (OTH)
AF:
AC:
5806
AN:
49826
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
8919
17838
26756
35675
44594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4420
8840
13260
17680
22100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00816 AC: 849AN: 104078Hom.: 26 Cov.: 0 AF XY: 0.00842 AC XY: 409AN XY: 48572 show subpopulations
GnomAD4 genome
AF:
AC:
849
AN:
104078
Hom.:
Cov.:
0
AF XY:
AC XY:
409
AN XY:
48572
show subpopulations
African (AFR)
AF:
AC:
560
AN:
24108
American (AMR)
AF:
AC:
69
AN:
9918
Ashkenazi Jewish (ASJ)
AF:
AC:
8
AN:
2992
East Asian (EAS)
AF:
AC:
35
AN:
3708
South Asian (SAS)
AF:
AC:
10
AN:
2974
European-Finnish (FIN)
AF:
AC:
10
AN:
3616
Middle Eastern (MID)
AF:
AC:
0
AN:
200
European-Non Finnish (NFE)
AF:
AC:
140
AN:
54454
Other (OTH)
AF:
AC:
17
AN:
1386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
41
81
122
162
203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
4
Tuberous sclerosis 1 (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not provided (2)
-
-
1
Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1854465:Tuberous sclerosis 1 (1)
-
-
1
Tuberous sclerosis syndrome (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.